Lifecore Biomedical, Inc.

NasdaqGS:LFCR Stock Report

Market Cap: US$201.5m

Lifecore Biomedical Dividend

Dividend criteria checks 0/6

Lifecore Biomedical does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield0.4%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$2.10
Dividend yield forecast in 3Yn/a

Recent dividend updates

No updates

Recent updates

White Falcon Capital - Lifecore Biomedical: Potential For Rapid Growth In Earnings And FCF Surge

Apr 20

Would Lifecore Biomedical (NASDAQ:LFCR) Be Better Off With Less Debt?

Jun 30
Would Lifecore Biomedical (NASDAQ:LFCR) Be Better Off With Less Debt?

Landec Non-GAAP EPS of -$0.32, revenue of $43.35M

Oct 06

Landec receives Nasdaq's notification on delayed annual report filing

Sep 09

Laughing Water Capital - Landec Corp. : A High Quality CDMO

Jul 27

Landec (NASDAQ:LNDC) Takes On Some Risk With Its Use Of Debt

Jun 24
Landec (NASDAQ:LNDC) Takes On Some Risk With Its Use Of Debt

Analysts Have Been Trimming Their Landec Corporation (NASDAQ:LNDC) Price Target After Its Latest Report

Apr 08
Analysts Have Been Trimming Their Landec Corporation (NASDAQ:LNDC) Price Target After Its Latest Report

Landec (NASDAQ:LNDC) Has A Somewhat Strained Balance Sheet

Mar 21
Landec (NASDAQ:LNDC) Has A Somewhat Strained Balance Sheet

Here's What's Concerning About Landec's (NASDAQ:LNDC) Returns On Capital

Nov 30
Here's What's Concerning About Landec's (NASDAQ:LNDC) Returns On Capital

Optimistic About Landec's Strategic Initiatives And Sodium Hyaluronate Products

Nov 05

Landec Still In Play As An Activist Investment

Aug 20

Is Landec (NASDAQ:LNDC) Using Too Much Debt?

May 25
Is Landec (NASDAQ:LNDC) Using Too Much Debt?

Is Landec (NASDAQ:LNDC) Using Too Much Debt?

Feb 24
Is Landec (NASDAQ:LNDC) Using Too Much Debt?

The CEO, President & Director of Landec Corporation (NASDAQ:LNDC), Albert Bolles, Just Bought 38% More Shares

Jan 20
The CEO, President & Director of Landec Corporation (NASDAQ:LNDC), Albert Bolles, Just Bought 38% More Shares

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if LFCR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if LFCR's dividend payments have been increasing.


Dividend Yield vs Market

Lifecore Biomedical Dividend Yield vs Market
How does LFCR dividend yield compare to the market?
SegmentDividend Yield
Company (LFCR)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.8%
Industry Average (Life Sciences)0.4%
Analyst forecast in 3 Years (LFCR)n/a

Notable Dividend: Unable to evaluate LFCR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate LFCR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate LFCR's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as LFCR has not reported any payouts.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.